Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.88 |
| ▸ | CHAT | P28329 | 2/20 | 0.84 |
| ▸ | EP300 | Q09472 | 3/20 | 0.83 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.83 |
| ▸ | AURKA | O14965 | 2/20 | 0.83 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.83 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4367366 | 1.00 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL60439 | 1.00 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL29425568 | 1.00 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL28130999 | 1.00 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL4358381 | 1.00 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA | |
| Phosphoric Acid SCHEMBL30705430 | 0.99 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Methane SCHEMBL18038085 | 0.99 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Methane SCHEMBL28198292 | 0.99 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Acetic Acid SCHEMBL30464957 | 0.98 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Acetic Acid SCHEMBL26923237 | 0.98 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250092427-A1 | Fungal Cannabinoids | LYGOS, INC. | 2025-03-20 | — | — | US | claimed |
| US-20240360425-A1 | ENGINEERED ENZYMES, CELLS, AND METHODS FOR PRODUCING CANNABINOID PRECURSORS AND CANNABINOIDS | CELLIBRE, INC. | 2024-10-31 | — | — | US | claimed |
| US-12043860-B2 | Advanced production of cannabinoids in yeast | LYGOS, INC. (US) | 2024-07-23 | — | — | US | claimed |
| CN-117980473-A | Organisms producing less crotonic acid | 环球生物能源公司 | 2024-05-03 | — | — | CN | claimed |
| CN-116987681-A | 10-deacetylbaccatin III 10 beta-O-acetyltransferase mutant and application thereof | 中国医学科学院药物研究所 | 2023-11-03 | — | — | CN | claimed |
| WO-2023185760-A1 | BUTYRIC ACID-PRODUCING PROBIOTIC, METHOD FOR CONSTRUCTING SAME, AND USE THEREOF | 北京航空航天大学 | 2023-10-05 | — | — | WO | claimed |
| US-11688519-B2 | Method and system for monitoring the gut health of an individual | TATA CONSULTANCY SERVICES LIMITED (IN) | 2023-06-27 | — | — | US | claimed |
| US-20220403346-A1 | PRODUCTION OF CANNABINOIDS | BIOMEDICAN, INC. | 2022-12-22 | — | — | US | claimed |
| WO-2022241299-A2 | ENGINEERED ENZYMES, CELLS, AND METHODS FOR PRODUCING CANNABINOID PRECURSORS AND CANNABINOIDS | CELLIBRE, INC. (US) | 2022-11-17 | — | — | WO | claimed |
| US-20220220515-A1 | Advanced Production of Cannabinoids in Yeast | LYGOS, INC. | 2022-07-14 | — | — | US | claimed |
| US-20220213513-A1 | PRODUCTION OF CANNABINOIDS | BIOMEDICAN, INC. | 2022-07-07 | — | — | US | claimed |
| EP-4017972-A1 | PRODUCTION OF CANNABINOIDS | Biomedican, Inc. (US) | 2022-06-29 | — | — | EP | claimed |
| US-11293038-B2 | Production of cannabinoids in yeast | LYGOS, INC. | 2022-04-05 | — | — | US | claimed |
| CN-112608951-A | Fermentation method for improving butyric acid yield | 驻马店华中正大有限公司 | 2021-04-06 | — | — | CN | claimed |
| WO-2026106979-A1 | PROCESSES AND SYSTEMS FOR FERMENTATIVE ALCOHOL PRODUCTION AND RECOVERY | GEVO, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-20260132429-A1 | PROCESSES AND SYSTEMS FOR FERMENTATIVE ALCOHOL PRODUCTION AND RECOVERY | GEVO INC (US) | 2026-05-14 | — | — | US | disclosed |
| CN-121950743-A | Butyryl-CoA-transferase from bottom of white spirit pit and application thereof | 天津科技大学 | 2026-05-01 | — | — | CN | disclosed |
| CN-110016452-A | One plant has prebiotic active production butyric DG1 and its cultural method and application | 汕头大学 | 2019-07-16 | — | — | CN | disclosed |
| CN-110004094-A | One plant has prebiotic active clostridium butyricum CG3 and its cultural method and application | 汕头大学 | 2019-07-12 | — | — | CN | disclosed |
| CN-103097538-A | Branched chain fatty acids and their biological production | PROCTER & GAMBLE | 2013-05-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132429-A1 | PROCESSES AND SYSTEMS FOR FERMENTATIVE ALCOHOL PRODUCTION AND RECOVERY | GK, ADH1C, ADH5 | NAA50 1298/4885CHAT 2608/4885EP300 1732/4885 |
| US-20220213513-A1 | PRODUCTION OF CANNABINOIDS | DGAT2, GGPS1, UGCG | NAA50 287/4885CHAT 2061/4885EP300 1875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.